# US 2001/0024640 A1 · Ultrasound contrast agents and methods of making and using them

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024640 A1
- Document ID: US20010024640A1
- Status: Published application
- Kind: A1
- Application number: 09/748,120
- Filed: 2000-12-27
- Published: 2001-09-27
- Earliest claimed: 1990-04-02
- Inventors: Michel Schneider; Daniel Bichon; Philippe Bussat; Jerome Puginier; Eva Hybl; Feng Yan; Pascal Grenier; Nadine Garcel; Marie-Bernadette Barrau
- Web page: https://patentgrep.com/patent/US20010024640A1

## CPC

- A61K 49/223: {Microbubbles, hollow microspheres, free gas bubbles, gas microspheres}
- A61B 8/481: {involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Gas filled microbubble and microballoon suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. One can impart outstanding resistance against collapse under pressure to these gas-filled microbubbles and microballoons used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003. Contrast agents with particular mixtures of gases are disclosed that have advantageous properties. Dry formulations useful in making the contrast agents are also disclosed.

## Claims

### Claim 1

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a freon.

### Claim 2

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is an organic compound containing one or more carbon atoms and fluorine.

### Claim 3

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a halogenated hydrocarbon.

### Claim 4 (depends on 1)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 1; and,
(2) echographically imaging said body.

### Claim 5 (depends on 2)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 2; and,
(2) echographically imaging said body.

### Claim 6 (depends on 3)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 3; and,
(2) echographically imaging said body.

### Claim 7 (depends on 1)

A method of making the ultrasound contrast agent of claim 1 comprising the step of: utilizing a gas that is a freon.

### Claim 8 (depends on 2)

A method of making the ultrasound contrast agent of claim 2 comprising the step of: utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 9 (depends on 3)

A method of making the ultrasound contrast agent of claim 3 comprising the step of: utilizing a gas that is a halogenated hydrocarbon.

### Claim 10

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a freon.

### Claim 11

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is an organic compound containing one or more carbon atoms and fluorine.

### Claim 12

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a halogenated hydrocarbon.

### Claim 13 (depends on 10)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 10; and,
(2) echographically imaging said body.

### Claim 14 (depends on 11)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 11; and,
(2) echographically imaging said body.

### Claim 15 (depends on 12)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 12; and,
(2) echographically imaging said body.

### Claim 16 (depends on 10)

A method of making the ultrasound contrast agent of claim 10 comprising the step of:
utilizing a gas that is a freon.

### Claim 17 (depends on 11)

A method of making the ultrasound contrast agent of claim 11 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 18 (depends on 12)

A method of making the ultrasound contrast agent of claim 12 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 19

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is a freon.

### Claim 20

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 21

An ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: air, CO2 and nitrogen; and a second compound that is a halogenated hydrocarbon.

### Claim 22 (depends on 19)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 19; and,
(2) echographically imaging said body.

### Claim 23 (depends on 20)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 20; and,
(2) echographically imaging said body.

### Claim 24 (depends on 21)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 21; and,
(2) echographically imaging said body.

### Claim 25 (depends on 19)

A method of making the ultrasound contrast agent of claim 19 comprising the step of:
utilizing a gas that is a freon.

### Claim 26 (depends on 20)

A method of making the ultrasound contrast agent of claim 20 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 27 (depends on 21)

A method of making the ultrasound contrast agent of claim 21 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 28

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a freon.

### Claim 29

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is an organic compound containing one or more carbon atoms and fluorine.

### Claim 30

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a halogenated hydrocarbon.

### Claim 31 (depends on 28)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 28; and,
(2) echographically imaging said body.

### Claim 32 (depends on 29)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast agent made from the dry formulation of claim 29; and,
(2) echographically imaging said body.

### Claim 33 (depends on 30)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast agent made from the dry formulation of claim 30; and,
(2) echographically imaging said body.

### Claim 34 (depends on 28)

A method of making the dry formulation of claim 28 comprising the step of:
utilizing a gas that is a freon.

### Claim 35 (depends on 29)

A method of making the dry formulation of claim 29 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 36 (depends on 30)

A method of making the dry formulation of claim 30 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 37

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is a freon.

### Claim 38

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 39

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: air, CO2 and nitrogen; and a second compound that is a halogenated hydrocarbon.

### Claim 40 (depends on 37)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 37; and,
(2) echographically imaging said body.

### Claim 41 (depends on 38)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 38; and,
(2) echographically imaging said body.

### Claim 42 (depends on 39)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 39; and,
(2) echographically imaging said body.

### Claim 43 (depends on 37)

A method of making the dry formulation of claim 37 comprising the step of:
utilizing a gas that is a freon.

### Claim 44 (depends on 38)

A method of making the dry formulation of claim 38 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 45 (depends on 39)

A method of making the dry formulation of claim 39 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 46

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a freon.

### Claim 47

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is an organic compound containing one or more carbon atoms and fluorine.

### Claim 48

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a halogenated hydrocarbon.

### Claim 49 (depends on 46)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection a contrast agent made from the dry formulation of claim 46; and,
(2) echographically imaging said body.

### Claim 50 (depends on 47)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection a contrast agent made from the dry formulation of claim 47; and,
(2) echographically imaging said body.

### Claim 51 (depends on 48)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection a contrast agent made from the dry formulation of claim 48; and,
(2) echographically imaging said body.

### Claim 52 (depends on 46)

A method of making the dry formulation of claim 46 comprising the step of:
utilizing a gas that is a freon.

### Claim 53 (depends on 47)

A method of making the dry formulation of claim 47 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 54 (depends on 48)

A method of making the dry formulation of claim 48 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 55

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is a freon.

### Claim 56

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: CO2, nitrogen, N2O, methane and butane; and a second compound that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 57

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microbubbles in a physiologically compatible aqueous carrier,
wherein said suspension comprises a film-forming surfactant that is a phospholipid, and
wherein the gas in the microbubbles is a mixture of a first compound selected from the group consisting of: air, CO2 and nitrogen; and a second compound that is a halogenated hydrocarbon.

### Claim 58 (depends on 55)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 55; and,
(2) echographically imaging said body.

### Claim 59 (depends on 56)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 56; and,
(2) echographically imaging said body.

### Claim 60 (depends on 57)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 57; and,
(2) echographically imaging said body.

### Claim 61 (depends on 55)

A method of making the dry formulation of claim 55 comprising the step of:
utilizing a gas that is a freon.

### Claim 62 (depends on 56)

A method of making the dry formulation of claim 56 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 63 (depends on 57)

A method of making the dry formulation of claim 57 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 64

An ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a freon.

### Claim 65

An ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is an organic compound containing one or more carbon atoms and fluorine.

### Claim 66

An ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a halogenated hydrocarbon.

### Claim 67 (depends on 64)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 64; and,
(2) echographically imaging said body.

### Claim 68 (depends on 65)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 65; and,
(2) echographically imaging said body.

### Claim 69 (depends on 66)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 66; and,
(2) echographically imaging said body.

### Claim 70 (depends on 64)

A method of making the ultrasound contrast agent of claim 64 comprising the step of: utilizing a gas that is a freon.

### Claim 71 (depends on 65)

A method of making the ultrasound contrast agent of claim 65 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 72 (depends on 66)

A method of making the ultrasound contrast agent of claim 66 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 73

An ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a mixture of a first compound selected from the group consisting of: air, CO2 and nitrogen; and a second compound that is a halogenated hydrocarbon.

### Claim 74 (depends on 73)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection the ultrasound contrast agent of claim 73; and,
(2) echographically imaging said body.

### Claim 75 (depends on 73)

A method of making the ultrasound contrast agent of claim 73 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 76

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a freon.

### Claim 77

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier, wherein the gas in the microballoons is an organic compound containing one or more carbon atoms and fluorine.

### Claim 78

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a halogenated hydrocarbon.

### Claim 79 (depends on 76)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 76; and,
(2) echographically imaging said body.

### Claim 80 (depends on 77)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 77; and,
(2) echographically imaging said body.

### Claim 81 (depends on 78)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 78; and,
(2) echographically imaging said body.

### Claim 82 (depends on 76)

A method of making the dry formulation of claim 76 comprising the step of:
utilizing a gas that is a freon.

### Claim 83 (depends on 77)

A method of making the dry formulation of claim 77 comprising the step of:
utilizing a gas that is an organic compound containing one or more carbon atoms and fluorine.

### Claim 84 (depends on 78)

A method of making the dry formulation of claim 78 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.

### Claim 85

A dry formulation which, upon mixing with an aqueous carrier phase, will generate an ultrasound contrast agent comprising:
a suspension of gas filled microballoons in a physiologically compatible aqueous carrier,
wherein the gas in the microballoons is a mixture of a first compound selected from the group consisting of: air, CO2 and nitrogen; and a second compound that is a halogenated hydrocarbon.

### Claim 86 (depends on 85)

A method of imaging an organ in a living body, said method comprising the steps of:
(1) administering to said body by injection an ultrasound contrast made from the dry formulation of claim 85; and,
(2) echographically imaging said body.

### Claim 87 (depends on 85)

A method of making the dry formulation of claim 85 comprising the step of:
utilizing a gas that is a halogenated hydrocarbon.
